AbbVie has big plans to grow sales for Humira follow-ups Skyrizi and upadacitinib. Early into its Skyrizi launch for psoriasis, the company has offered discounts on its megablockbuster Humira to ...

FILE - Packaging for AbbVie's drug, Humira. Patients who take the autoimmune disease treatment can get some price relief when lower-cost, biosimilar versions are included on health plan formularies.

“Humira Support Tool Ordering Service for Patients” is a free-of-charge service that assists patients on Humira therapy by directly delivering support tools to their home or other requested location.

AbbVie ($ABBV) relies on its top seller Humira to bring home the bacon, bringing in more than half its revenues even as AbbVie prepares for increased biosimilar ...

Please provide your email address to receive an email when new articles are posted on . AbbVie reported a worldwide net revenue of $12.31 billion and a 0.7% increase in its first quarter. Global net ...